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cells: Calcium oxalate and oxalate ions effects.
Background. The interaction between tubular epithelial cells
and calcium oxalate crystals or oxalate ions is a very precari-
ous event in the lithogenesis. Urine contains ions, glycoproteins
and glycosaminoglycans that inhibit the crystallization process
and may protect the kidney against lithogenesis. We examined
the effect of oxalate ions and calcium oxalate crystals upon the
synthesis of glycosaminoglycans in distal [Madin-Darby canine
kidney (MDCK)] and proximal (LLC-PK1) tubular cell lines.
Methods. Glycosaminoglycan synthesis was analyzed by
metabolic labeling with 35S-sulfate and enzymatic digestion
with specific mucopolysaccharidases. Cell death was assessed
by fluorescent dyes and crystal endocytosis was analised by flow
cytometry.
Results. The main glycosaminoglycans synthesized by both
cells were chondroitin sulfate and heparan sulfate most of them
secreted to the culture medium or present at cellular surface.
Exposition of MDCK cells to oxalate ions increased apoptosis
rate and the incorporation of 35S-sulfate in chondroitin sulfate
and heparan sulfate, while calcium oxalate crystals were endo-
cyted by LLC-PK1, induced necrotic cell death, and increased
35S-sulfate incorporation in glycosaminoglycans. These effects
seem to be specific and due to increased biosynthesis, since hy-
droxyapatite and other carboxylic acid did not induced cellular
death or glycosaminoglycan synthesis and no changes in sulfa-
tion degree or molecular weight of glycosaminoglycans could
be detected. Thapsigargin inhibited the glycosaminoglycan syn-
thesis induced by calcium oxalate in LLC-PK1, suggesting that
this effect was sensitive to the increase in cytosolic calcium.
Conclusion. Tubular cells may increase the synthesis of gly-
cosaminoglycans to protect from the toxic insult of calcium ox-
alate crystals and oxalate ions, what could partially limit the
lithogenesis.
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Nephrolithiasis is a multifactorial disease. Many as-
pects of its pathogenesis have been widely investigated.
One of them is the interaction between calcium oxalate,
the crystal present in most of the human stones, and tubu-
lar epithelial cells. The effects of oxalate ion upon tubular
cells have also been studied. High oxalate concentrations
provide conditions for precipitation of calcium oxalate
crystals in the urine, and both calcium oxalate crystal
and oxalate ions induce renal injury [1, 2], which gen-
erates cellular debris and promotes crystal nucleation.
The surviving tubular cells may adapt to the toxic insult
by inducing cell proliferation, and synthesis of extracellu-
lar matrix (ECM) proteins and crystallization inhibitors
[3, 4].
It has been previously shown that glycosaminoglycans
inhibit the growth and aggregation of calcium oxalate
crystals in vitro [5–7]. The logical extension of these ob-
servations was that the urinary glycosaminoglycans could
function as inhibitors of calcium oxalate urolithiasis. If
endogenous glycosaminoglycans are important factors in
the inhibitors of urolithiasis, one might expect significant
differences in the urinary glycosaminoglycan levels of
stone formers in comparison to nonstone formers. In fact,
our laboratory has shown a definite decrease in the uri-
nary glycosaminoglycan concentration of stone forming
subjects, both children and adults [8]. Furthermore, there
are evidences suggesting that the adhesion of calcium ox-
alate crystals to Madin-Darby canine kidney (MDCK)
cells can be inhibited by heparan sulfate, chondroitin 4-
sulfate, and hyaluronic acid [9–11].
In humans, the main urinary glycosaminoglycans are
chondroitin sulfate (∼80% of total) and heparan sulfate
(∼20% of total), with small amounts of dermatan sulfate
(1% to 2%) and trace amounts of hyaluronic acid and
keratan sulfate. Similar glycosaminoglycan compositions
have also been found in other mammalian species such
as cat [12] and horse [13], but not rat, which excretes
lower proportions of chondroitin sulfate [14, 15]. There
are evidences suggesting that the urinary chondroitin sul-
fate is of systemic origin and filtered in the glomerulus
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[12, 16], while the urinary heparan sulfate and, possibly,
dermatan sulfate could be of systemic origin or come from
the kidney and/or urinary tract [12].
Heparan sulfate is the main kidney glycosaminoglycan,
occurring both in cell surface proteoglycans of the syn-
decan and glypican families, and in perlecan, the main
basement membrane proteoglycan [17]. Other base-
ment membrane proteoglycan is bamacan. It is a chon-
droitin sulfate proteoglycan expressed transiently during
nephrogenesis that disappears from the glomerular base-
ment membrane (GBM) upon maturation [18]. Further-
more, the expression of the core protein of four small
proteoglycans, decorin, biglycan, fibromodulin, and lu-
mican, has been observed in the renal interstitium, with
accumulation around tubules. Low expression of these
core proteins was also found in mesangial matrix [19].
But their glycosylation was not assessed.
Decorin core protein was also detected in the urine
and glomerulus of patients with membranous nephropa-
thy [19] and IgA nephropathy [20], but not in normal
subjects. Moreover, we have previously shown that
mesangial cells isolated from diabetic rats synthesized
in vitro increased amounts of dermatan sulfate proteo-
glycans of the small leucine-rich proteoglycan family
(SLRPG), and this increase was proportional to the du-
ration of diabetes [21]. Increased expression of dermatan
sulfate proteoglycans was also shown in experimental
models of chronic renal failure [15] and diabetes mellitus
[14] in rats.
On the other hand, increased expression of syndecan-
1, a cell surface heparan sulfate proteoglycan, has
been demonstrated in rat kidney during calcium ox-
alate nephrolithiasis [22]. The increased expression of
syndecan-1 and heparan sulfate in a cell line derived from
MDCK cells led to a decrease in calcium oxalate attach-
ment to these cells [23], suggesting a preventive role for
this proteoglycan in calcium oxalate nephrolithiasis.
The goal of the present study was to investigate the
effects of calcium oxalate crystals and oxalate ions upon
the synthesis of glycosaminoglycans by distal (MDCK)
and proximal (LLC-PK1) tubular epithelial cell lines, and
upon cell death. The effects of other crystal (hydroxya-
patite) also commonly found in renal stones, and other
carboxylic anion (formate) was also investigated, as well
as the effects of thapsigargin, a calcium ionophore.
METHODS
Materials
Potassium oxalate (K2-oxalate), NaHCO3, N(2-
hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid)
(Hepes), NH4OH, and ethanol were purchased from
Merck EGA (Darmstadt, Germany). Chondroitinase
AC from Flavobacterium heparinum was prepared as
described by Aguiar et al [24], and heparitinase II,
also from F. heparinum, was prepared as described by
Nader et al [25]. Chondroitin 4-sulfate (from whale
cartilage) and chondroitin 6-sulfate (from shark car-
tilage) were purchased from Seikagaku Kogyo Co.,
Ltd. (Tokyo, Japan). Heparan sulfate (from bovine
pancreas) was obtained from Opocrim Laboratories
(Modena, Italy). Hyaluronic acid from bovine tracheal
cartilage and umbilical cord, Dulbecco’s modified
Eagle’s medium (DMEM), penicillin/streptomycin,
phosphate-buffered saline (PBS), papain, Triton X-100,
Trizma base (Tris[hydroxymethyl]aminomethane),
x-ray film (Kodak SSB), toluidine blue, thapsigargin,
acrydine orange, ethidium bromide, and HOE 33342
[(bisbenzimide Hoe 33342 (2′-(etoxifenil)-5-(4-metil-
1-piperazinil)-2,5′-bi-benzimidazole and HCl)] were
purchased from Sigma Chemical Co. (St. Louis, MO,
USA). Agarose were purchased from Bio-Rad Labora-
tories (Richmond, CA, USA). Cetavlon (cetyl, trimethyl
ammonium bromide), N,N-methylenebisacrylamide,
1,3-diaminopropane (PDA) and ethylenediamine were
from Aldrich Chemical Co. (Milwaukee, WI, USA).
Fetal bovine serum (FBS) was from Invitrogen (Carls-
bad, CA, USA). Trypsin-ethylenediaminetetraacetic
acid (EDTA) solution was purchased from Cultilab (Sa˜o
Paulo, SP, Brazil). H235SO4 was purchased from Instituto
de Energia Nuclear (Sa˜o Paulo, SP, Brazil) and Whatman
Paper number 1 was from Whatman International, Ltd.
(W & R Balston Ltd., Maidstone, England).
Tubular cell culture
Distal (MDCK) and proximal (LLC-PK1) tubular ep-
ithelial cell lines (American Type Culture Collection,
Mannassas, VA, USA) were cultured in DMEM supple-
mented with 5% FBS, glucose and antibiotics at 37◦C,
under 5% CO2 humidified atmosphere. At confluence,
the cells were detached with trypsin, collected by cen-
trifugation, resuspended in DMEM, and subcultured in
25 cm2 culture plastic flasks.
Preparation of calcium oxalate crystals
Solutions of CaCl2 (0.4 mol/L, 100 mL) and K2-oxalate
(0.4 mol/L, 100 mL) were added to distilled and deion-
ized water (300 mL) by constant dripping for 2 hours
(1 mL/min). This suspension was maintained under con-
tinuous stirring at 75◦C for 5 hours, and then washed with
deionized water to remove the KCl present. The remain-
ing saturated solution was maintained at 37◦C for 15 days
for calcium oxalate crystallization. Calcium oxalate crys-
tals were sterilized in ethylene oxide or steam autoclave
and culture medium before FBS was added. No differ-
ence was observed between the both procedures. The
suspension was sonicated for 15 minutes to obtain par-
ticles of uniform size.
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Fig. 1. Agarose gel electrophoresis (A) and relative amounts of 35S-glycosaminoglycans (B) from each cell fraction obtained from control cultures
of Madin-Darby canine kidney (MDCK) and LLC-PK1 cell lines. Cells were incubated with H235SO4 for the metabolic labeling of proteoglycans.
After 24 hours, the culture medium, cellular surface, intracellular compartment, and extracellular matrix fractions were collected, and the 35S-
glycosaminoglycans were isolated as described in the text. Aliquots (5 lL) of these samples were submitted to agarose gel electrophoresis in 0.05
mol/L 1,3-diaminopropane-acetate buffer, pH 9 (PDA). The radioactive compounds were visualized by radioautography in the Cyclone Phorphor
Image System of the gel slabs and the areas containing 35S-labeled compounds were scrapped and the radioactivity was measured in a liquid
cintillation counter. Abbreviations are: CS, chondroitin sulfate; HS, heparan sulfate; Or, origin. Chondroitin sulfate and heparan sulfate quantities
are expressed percentage. Data are mean ± standard error of five experiments. ∗P < 0.05 was considered significant.
Exposure of tubular epithelial cells to calcium oxalate
or K2-oxalate
Prior to the experiments, cells were transferred to a
6-well plate (1 × 105 cells/well) and maintained under
the culture conditions for 3 days. Previously, we notice
that tubular cells were significantly affected by exposi-
tion to deprived culture medium (DMEM-BASE), so we
chose to expose tubular cells to oxalate and calcium ox-
alate crystals diluted in DMEM culture medium to con-
trol experimental conditions. At confluence, MDCK and
LLC-PK1 were exposed for 24 hours to either DMEM
(without FBS, control) or DMEM containing calcium
oxalate crystals (100, 200, 400, or 500 lg/mL, correspond-
ing to 0.78, 1.56, 3.12, or 3.9 mmol/L, respectively), K2-
oxalate (0.5, 1.0, 2.0, and 4.0 mmol/L), sodium formate
(4.0 mmol/L), hydroxyapatite (calcium phosphate) crys-
tals (500 lg/mL), or thapsigargin (2.0 lmol/L).
At the same time, H235SO4 (100 lCi/mL) was also
added to the culture medium for the metabolic labeling of
the glycosaminoglycans. The addition of H235SO4 did not
modify the pH of culture medium. After 24-hour incuba-
tion, the medium, cell surface, intracellular fraction, and
ECM fraction were obtained as previously described [26,
27]. In brief, 1 mL of the culture medium was collected
in a centrifuge tube and labeled “medium fraction.” The
cells were incubated with Triton X-100 (0.5%) solution
in 10 mmol/L Tris-HCl, pH 7.4, buffers. This buffer al-
lowed removing the cellular surfaces without lysing the
cell. After 5 minutes’ incubation in an ice bath, under agi-
tation, the supernatant solution was collected and labeled
as “cell surface.” Subsequently, NH4OH (0.02 mol/L) so-
lution in the same buffer was added to the phase. After
5 minutes’ incubation in an ice bath under agitation, the
solution was collected and labeled as “cell fraction.” A
sodium dodecyl sulfate (SDS) (2%) solution in the same
buffer was added and the residue was suspended with a
cell scrapper. The solution was collected and labeled as
“ECM.” All steps were followed by observation under a
phase contrast inverted microscope.
In some experiments, only medium and cell fractions
were extracted. The culture medium (1 mL) was collected
and labeled “medium fraction.” The cells were treated
with 3.5 mol/L urea in 50 mmol/L Tris-HCl, pH 7.4, and
scraped from the flask surface with a cell scraper. The
solution and transferred to a centrifuge tube and labeled
“cell extract” [27].
In both experimental situations, chondroitin sulfate
and heparan sulfate (100 lg each) were added, as carriers,
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Fig. 2. 35S-sulfate incorporation in glycosaminoglycans by LLC-PK1 and Madin-Darby canine kidney (MDCK) in presence of either calcium
oxalate (CaOx) (0 to 500 lg/mL) or (K2Ox) (0 to 4.0 mmol/L). The experiment was performed as described in the text. Quantitative results are
expressed as counts per minute (cpm). Data are mean ± standard error of five experiments. ∗P < 0.05 was considered significant.
Table 1. Relative amounts of disaccharides formed by chondroitinase AC and heparitinase II from 35S-chondroitin sulfate and 35S-heparan
sulfate synthesized by Madin-Darby canine kidney (MDCK) exposed to K2-oxalate (4.0 mmol/L)
and LLC-PK1 exposed to calcium oxalate (500 lg/mL)
Products formed from
Chondroitin sulfate Heparan sulfate
Cell line Treatment Di4S% Di6S% DiNAc 6S% DiNS% DiNS 6S%
LLC-PK1 Control 38 62 18 28 54
Calcium oxalate (500 lg/mL) 43 57 39 27 34
MDCK Control 48 52 25 21 54
K2-oxalate (4.0 mM) 47 53 27 21 52
Abbreviations are: Di4S, 2-acetamido-2deoxy-3-O-(4-enepyranosyl-uronic acid)-4-O-sulfo-D-galactose; Di6S, 2-acetamido-2deoxy-3-O-(4-enepyranosyl-uronic
acid)-6-O-sulfo-D-galactose; DiNS, 2-sulfamino-2-deoxy-4-O-(D-gluco-4-enepyranosyluronic acid)-D-glucose; DiNAc 6S, 2-acetamido-2-deoxy-4-O-(D-gluco-4-
enepyranosyl-uronic acid)-6-O-sulfo-D-glucose; DiNS 6S, 2-sulfamino-2-deoxy-4-O-(D-gluco-4-enepyranosyluronic acid)-6-O-sulfo-D-glucose.
MDCK and LLC-PK1 cells were exposed to K2-oxalate or calcium oxalate during 24 hours. Culture medium and cell fractions were collected and 35S-
glycosaminoglycans were extracted as described in the Methods section. The glycosaminoglycans thus obtained were incubated with specific mucopolysaccharidases
and the disaccharides thus formed were identified by paper chromatography.
to each fraction. After addition of 3 volumes of ethanol,
the mixtures were maintained at − 20◦C for 24 hours. The
precipitates formed were collected by centrifugation and
vacuum dried.
For the glycosaminoglycan extraction, the precipitates
formed in each fraction were resuspended in 100 lL of
phosphate-cysteine buffer (pH 6.5) containing EDTA
and 100 lg of papain.
Aliquots (5 lL) of each fraction and a standard
aliquot containing chondroitin sulfate and heparan sul-
fate were submitted to agarose gel electrophoresis in 0.05
mol/L 1,3-diaminopropane-actate buffer (pH 9) [28, 29].
The 35S-labeled compounds were visualized by expo-
sure of the agarose gel slabs (after fixation, drying, and
staining with toluidine blue) to Kodak x-ray film for
1 day.
For identification the gel bands were compared to
chondroitin sulfate and heparan sulfate aliquots or de-
graded with specific mucopolysaccharidases (chondroiti-
nase AC and heparitinase II).
For quantification, they were scraped of the gels and
counted in Ultima Gold in a Beckman 6800 liquid
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Fig. 3. Relative amounts of 35S-chondroitin sulfate and 35S-heparan sulfate synthesis by Madin-Darby canine kidney (MDCK) and LLC-PK1 in
presence of calcium oxalate (CaOx) (0 to 500 lg/mL) or K2Ox (0 to 4.0 mmol/L). The experiment was performed as described in Fig. 2. Quantitative
results are expressed as counts per minute (cpm). Data are mean ± standard error of five experiments. ∗P < 0.05 was considered significant.
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Fig. 5. Effects of K2Ox and calcium oxalate
(CaOx) upon hyaluronic acid synthesis by
Madin-Darby canine kidney (MDCK) and
LLC-PK1. The experiment was performed as
described in Fig. 2, except that that hyaluronic
acid was measured in cell and medium frac-
tions of MDCK and LLC-PK1 cells exposed
to K2-oxalate (4.0 mmol/L) and calcium ox-
alate (500 lg/mL). Results were expressed
as concentration of hyaluronic acid (ng/mL).
Data are mean ± standard error of five exper-
iments. ∗P < 0.05 was considered significant.
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Fig. 6. Effect of K2Ox and calcium oxalate
(CaOx) treatment upon the cellular via-
bility (necrotic and apoptotic cell death)
on Madin-Darby canine kidney (MDCK)
and LLC-PK1. MDCK exposed to K2-
oxalate (0.5 to 4.0 mmol/L) and LLC-PK1
exposed to calcium oxalate (100 to 500
lg/mL) suspensions were centrifuges and
incubated with acrydine orange/ethidium
bromide solutions or HOE 33342 [(bisbenz-
imide Hoe 33342 (2′-(etoxifenil)-5-(4-metil-1-
piperazinil)-2,5′-bi-benzimidazole and HCl)]
dyes. Ethidium bromide (green) stains all cells
while acrydine orange (orange) is excluded
from viable cells. Green cells were consid-
ered viable while orange cells were considered
unviable. HOE 33342 stains the chromatin.
Blue cells were considered nonapoptotic and
condensed chromatin cells were considered
apoptotic. At least 100 cells were counted
and results expressed as percentage. Data are
mean ± standard error of five experiments.
∗P < 0.05 was considered significant.
scintillation spectrometer. The results were expressed as
counts per minute (cpm).
Molecular weight determinations were performed by
polyacrylamide gel electrophoresis (PAGE) as previously
described [30, 31].
Hyaluronic acid was measured as described by Martins
et al [32].
Calcium oxalate endocytosis experiments
Calcium oxalate endocytosis was determinate by flow
cytometry using 488 nm excitation. In brief, the flow cy-
tometer detects how the cell interacts with a focused laser
beam in terms of how the cell scatter the incident light and
emit fluorescence. In forward scatter light is diffracted at
low angles, generally proportional to cell size and the
side scatter light is reflected at high angles, proportional
to cell granularity and complexity and detected at 90◦ to
incident light axis.
Cultures of LLC-PK1 and MDCK cells were exposed,
respectively, to calcium oxalate (100 to 500 lg/mL) and
K2-oxalate (0.5 to 4.0 mmol/L), as described above. After
24 hours’ incubation, the cells were washed with PBS and
incubated with the trypsin-EDTA solution. These proce-
dures yield only cells containing internalized or strongly
adherent crystals. Cell suspensions (1 × 106 cells/mL)
were transferred to conical fluorescence-activated cell
sorter (FACS) tubes and immediately analyzed on a
FACScan flow cytometer (FacsCalibur analyzer; Becton-
Dickinson Immunocytometry Systems, Fullerton, CA,
USA). Data were acquired for up to 5 × 103 cells from
each sample.
Histograms of the light intensity were constructed for
each experimental situation and geometric mean of light
intensity of the cellular population was determinate. Cal-
cium oxalate crystals were excluded from analysis using a
gated analysis method based on forward light scatter and
side scatter. MDCK and LLC-PK1 complexity (granular-
ity) were considered as control parameters and compared
with the cellular complexity after calcium oxalate or K2-
oxalate exposition.
Cellular viability experiments
Necrotic and apoptotic cells were evaluated respec-
tively by acrydine orange/ethidium bromide and HOE
33342 dyes. MDCK and LLC-PK1 suspensions were
centrifuged, resuspended in PBS, and incubated with
acrydine orange/ethidium bromide solution for 5 to
15 minutes. Cells were than observed under light mi-
croscopy. Ethidium bromide stains all cells in green, while
acrydine orange is excluded from viable cells. HOE 33342
stains the chromatin. Blue cells were considered non-
apoptotic, and cell with condensed chromatin were con-
sidered apoptotic. At least 100 cells per culture were
counted, and the results were expressed as percentage
of necrotic or apoptotic cells.
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Fig. 7. Dot plot graphics. (A) Calcium oxalate (CaOx) crystals (R1), Madin-Darby canine kidney (MDCK) cells (R2), and MDCK plus calcium
oxalate crystals (R1 and R2). (B) Calcium oxalate crystals (R1), LLC-PK1 cells (R2), and LLC-PK1 plus calcium oxalate crystals (R1 and R2).
Confluents cultures of MDCK and LLC-PK1 were exposed to calcium oxalate (500 lg/mL) and analyzed at FACScan flow cytometer. Five thousand
cells cell from each experiment situation were acquired.
Statistical analysis
Results are given as mean ± SEM. Experimental and
control groups were compared by the t test of Student. P
values of less than 0.05 were considered significant.
RESULTS
Figure 1 shows that both MDCK and LLC-PK1 cell
lines synthesized a mixture of chondroitin sulfate and
heparan sulfate in different proportions. LLC-PK1 syn-
thesized 23.2% of chondroitin sulfate and 76.8% of
heparan sulfate, while MDCK synthesized 48.5% of
chondroitin sulfate and 51.5% of heparan sulfate. In both
cell lines, most of the glycosaminoglycans were present
in the culture medium and cell surface fractions (40% to
70%), while smaller portions were observed in intracel-
lular compartment (1% to 10%) and ECM (1% to 15%),
especially for LLC-PK1 cells.
Both cell lines were exposed to increasing concentra-
tions of K2-oxalate (0.5 to 4.0 mmol/L) and calcium ox-
alate (100 to 500 lg/mL) during 24 hours. The different
cell lines responded differentially to these treatments.
High concentrations of K2-oxalate increased the 35S-
sulfate incorporation in glycosaminoglycans by MDCK
cells, but had no significantly effects upon LLC-PK1
cells (Fig. 2). Both chondroitin sulfate and heparan sul-
fate were affected by K2-oxalate, but not by calcium
oxalate exposition (Fig. 3). In contrast calcium oxalate
increased the 35S-sulfate incorporation in LLC-PK1,
but there was no significantly effect on MDCK cells
(Fig. 2). Again both chondroitin sulfate and heparan sul-
fate were increased in culture medium and surface frac-
tions (Fig. 3).
In order to investigate if the effects of calcium oxalate
and K2-oxalate observed upon glycosaminoglycan syn-
thesis are specific for these salts, the effects of other crys-
tals also present in urinary stones (calcium phosphate
or hydroxyapatite) and formate, which is a carboxylic
acid (as oxalate) and shares oxalate transporter in LLC-
PK1 cells [33] were also analyzed. Figure 4 shows that
neither formate nor hydroxyapatite increased gly-
cosaminoglycans synthesis in the cell lines here studied.
This finding suggests that the effects of calcium oxalate
and K2-oxalate are specific.
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Fig. 8. Effect of K2Ox and calcium oxalate (CaOx) treatment in the cellular complexity on Madin-Darby canine kidney (MDCK) and LLC-PK1.
Calcium oxalate crystals are endocyted by tubular cells and increase cellular complexity (granularity). Confluents cultures of MDCK and LLC-PK1
were exposed to, respectively, K2-oxalate (0.5 to 4.0 mmol/L) and calcium oxalate (100 to 500 lg/mL) and analyzed at FACScan flow cytometer.
Five thousand cells from each experiment situation were acquired. The complexity (granularity) of MDCK and LLC-PK1 in the control situation
() was compared to the K2-oxalate or calcium oxalate situations (). The results were expressed as geometric mean (mean ± standard error of
five experiments). ∗P < 0.05 was considered significant.
To investigate if the increase in 35S-sulfate incorpo-
ration is due to increased sulfation degrees of the gly-
cosaminoglycans, these compounds were submitted to
enzymatic degradations with F. heparinum mucopolysac-
charidases. The products formed are shown in Table 1.
There were no significant changes in the relative propor-
tions of disaccharides that compose chondroitin sulfate
or heparan sulfate. Also, the modal molecular weights
of the polymers were unaltered, indicating that the
changes in 35S-sulfate incorporation in glycosaminogly-
cans are not due to changes in sulfation degrees or chain
length.
Furthermore, we observed that both MDCK and LLC-
PK1 cells synthesized and secreted to the culture medium
small amounts of hyaluronic acid (Fig. 5). Calcium oxalate
caused discrete increase in hyaluronic acid concentra-
tions upon LLC-PK1 cells and K2-oxalate upon MDCK
cells.
Figure 6 show that the treatment of MDCK cells with
K2-oxalate–induced apoptosis (34%) and necrosis (13%)
while calcium oxalate had no effect upon cellular viabil-
ity (data not shown). In opposition, calcium oxalate in-
creased, in a concentration-dependent manner, necrotic
cell death in LLC-PK1 cells and there was no difference
in the cellular viability after the K2-oxalate exposition in
these cells.
Figures 7 and 8 show that calcium oxalate crystals were
endocyted by both cells observed by the increase of the
side scatter. Calcium oxalate crystals concentrated at the
region R1 of the dot plot graphic, while MDCK or LLC-
PK1 cell concentrate at region R2. When calcium oxalate
crystals were exposed to both cells the concentration of
crystals decrease in the region R1 and the cell populations
migrated through side scatter axis of the dot plot graphic.
LLC-PK1 cells endocyted more calcium oxalate crys-
tals than MDCK, but no significant difference in cellular
complexity was observed after K2-oxalate exposition in
both cells. Also in LLC-PK1 significant effects were ob-
served upon glycosaminoglycan synthesis and cell necro-
sis. When the cells were exposed to K2-oxalate, some
calcium oxalate crystallizes in the culture medium. Never-
theless, very discrete changes in the cell complexity were
observed under these conditions, indicating a much lower
degree of calcium oxalate endocytosis (if any). So, the ef-
fects of K2-oxalate upon MDCK cells are possibly due to
the soluble ions.
To analyze the possible mechanism through which K2-
oxalate and calcium oxalate increased glycosaminogly-
cans synthesis, the effect of thapsigargin, an endoplas-
mic reticulum calcium adenosine triphosphatase (AT-
Pase) inhibitor was studied (Fig. 9). Thapsigargin had no
effect upon the glycosaminoglycan synthesis by both cell
Borges et al: Glycosaminoglycans in tubular epithelial cells 1639
lines. It had also no effect upon the increase in 35S-
glycosaminoglycan synthesis induced by K2-oxalate in
MDCK cells, but significantly inhibited the increase in
35S-chondroitin sulfate and 35S-heparan sulfate synthesis
and secretion to the culture medium induced by calcium
oxalate (500 lg/mL) in LLC-PK1 cells.
DISCUSSION
The results here presented show that tubular epithe-
lial cell lines (MDCK and LLC-PK1) synthesize a mix-
ture of chondroitin sulfate and heparan sulfate proteo-
glycans, predominantly secreted to the culture medium
and present in cellular surface. Hyaluronic acid was also
detected both in cell and medium fraction of both cell
lines.
MDCK and LLC-PK1 are affected differently by cal-
cium oxalate and oxalate ions. Upon MDCK cells, K2-
oxalate increased the incorporation of 35S-sulfate in
chondroitin and heparan sulfate found both in culture
medium, but calcium oxalate had no effect; on the
contrary, calcium oxalate increased the 35S-sulfate incor-
poration in glycosaminoglycans by LLC-PK1, while K2-
oxalate had no significant effect.
There was a small increase in hyaluronic acid concen-
trations, compared with chondroitin and heparan sulfate,
when MDCK were exposed to oxalate. Hyaluronic acid
has been implicated as a binding molecule for calcium
oxalate crystals [34]. It is possible that tubular cells limit
the synthesis of hyaluronic acid to avoid the increase in
adhesion of calcium oxalate crystals.
In both cell lines, 4-sulfated and 6-sulfated disaccha-
ride units compose chondroitin sulfate. Heparan sulfate
is composed by monosulfated (DiNS and DiNAc 6S) and
disulfated (DiNS 6S) disaccharides. The relative amounts
of these disaccharides were unaltered by the treatment
here used. Also, the glycosaminoglycan molecular weight
was not increased, indicating that the increase in 35S-
sulfate incorporation induced by K2-oxalate or calcium
oxalate are not due to increased sulfation or polymeriza-
tion degree.
Several papers have shown polarized synthesis of
proteoglycans by MDCK cells. Apical secretion of chon-
droitin sulfate proteoglycans [35] and expression of glyp-
ican, the main heparan sulfate proteoglycans at the
MDCK cell surface [36] have been reported. Most of
the proteoglycans are expressed in the apical surface of
MDCK cells that resemble distal tubular epithelial cells,
with only 17% at the basolateral side [37]. Furthermore,
Erickson and Couchman [38] reported the synthesis of
many ECM proteoglycans by these cells: perlecan, agrin,
and type XVIII collagen (heparan sulfate proteoglycans)
and biglycan, bamacan, and versican (chondroitin sulfate
proteoglycans). These proteoglycans are also present in
mammalian kidney tubules.
In contrast, there are only a few papers on the pro-
teoglycans synthesized by LLC-PK1 cells. Although they
are commonly used as a model of proximal tubular ep-
ithelial cells, the proteoglycans synthesized by these cells
were poorly characterized and only heparan sulfate pro-
teoglycans have been described [39, 40]. To our knowl-
edge, this is the first paper that describes the synthesis of
chondroitin sulfate proteoglycans by LLC-PK1 cells.
The effects of calcium oxalate crystals, as well as ox-
alate ions, upon MDCK and LLC-PK1 cells have been
widely investigated concerning their binding, internal-
ization, and induction of cell injury. Some results were
similar to the present study [1, 41], and others did not [2,
42], possibly because of the methodologies or conditions
employed. Nevertheless, their effects upon proteoglycan
synthesis have not been fully analyzed.
Up-regulation of heparan sulfate proteoglycan in rat
kidney [22] and increased expression of heparan sulfate
core protein mRNA in both proximal and distal tubules
[43] has been reported in nephrolithiasis. Although this
is the first paper to describe that calcium oxalate crys-
tals and oxalate ions have different effects upon the gly-
cosamnoglycan synthesis in different cell lines and that
keep resemblance to proximal (LLC-PK1) and distal
(MDCK) tubular epithelial cells.
K2-oxalate and calcium oxalate effects seem to be spe-
cific to, respectively, distal and proximal tubular cells. Nei-
ther exposition to hydroxyapatite nor formate increased
glycosaminoglycan synthesis in theses cells. Studies re-
port that MDCK cells bind 10 times more calcium oxalate
compared to brushite crystals (calcium phosphate) [44]. It
is possible that more calcium oxalate than hydroxiapatite
crystals bound to MDCK and LLC-PK1 and stimulated
glycosaminoglycan synthesis in LLC-PK1.
Several methodologies were used to study calcium
oxalate endocytosis, like light microscopy [41, 45] or
radioactive labeled crystals [42, 44]. Some of them used
different cell lines and observed different results in their
experimental conditions. Through flow cytometry, we
found that there was an increase in cellular complexity
when both cells were exposed to crystals, but LLC-PK1
cells seemed to endocyte more crystals than MDCK.
K2-oxalate induced necrotic and apoptotic cell deaths
in MDCK, these alterations are attributed mainly to di-
rect effects of oxalate ions and not by calcium oxalate
crystallization from culture medium, since K2-oxalate
did not change cellular complexity. Calcium oxalate in-
creased cellular complexity and induced necrotic cell
death in LLC-PK1, indicating that calcium oxalate effects
are attributed to crystal endocytosis.
These salt concentrations strongly correlate with the
concentration that induces 35S-chondroitin sulfate and
35S-heparan sulfate synthesis. Calcium oxalate crystals
and oxalate ions effects were observed in high con-
centrations, probably nonphysiologic, but experimental
conditions were improved to do not affect the normal
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Fig. 9. Effect of thapsigargin (Tap) (2.0 lmol/L) on the synthesis of 35S-chondroitin sulfate and 35S-heparan sulfate induced by K2Ox (4.0 mmol/L)
in Madin-Darby canine kidney (MDCK) and calcium oxalate (CaOx) (500 lg/mL, 3.9 mmol/L) in LL-PK1. Distal tubular cells exposed to either
Dulbecco’s modified Eagle’s medium (DMEM) without fetal calf serum (FCS) or K2-oxalate and K2-oxalate plus thapsigargin (2.0 lmol/L) and
proximal tubular cells exposed to DMEM without FCS or calcium oxalate and calcium oxalate plus thapsigargin (2.0 lmol/L) were incubated with
H235SO4. After 24 hours’ culture medium and cellular extract fractions were collected and the 35S-glycosaminoglycans were isolated. Aliquots of
culture medium and cell extract of each experimental situation were submitted to agarose gel electrophoresis. The 35S-glycosaminoglycans were
identified and quantified. Results were expressed as mean ± standard error of percentage between 35S-glycosaminoglycans obtained after each
treatment and, respectively, control situation. control (CTL), MDCK or LLC-PK1 culture medium and cell extract control; K2-oxalate, culture
medium, and cellular extract from MDCK exposed to K2-oxalate; K2-oxalate + thapsigargin, culture medium and cellular extract from MDCK
exposed to K2-oxalate plus thapsigargin. Calcium oxalate, culture medium, and cellular extract from LLC-PK1 exposed to calcium oxalate; calcium
oxalate + thapsigargin, culture medium, and cellular extract from LLC-PK1 exposed to calcium oxalate plus thapsigargin. Data are mean ± standard
error of five experiments. ∗P < 0.05 was considered significant different than control situation; ∗∗P < 0.05 was considered significant different than
calcium oxalate–treated situation.
pattern of glycosaminoglycan synthesis observed in these
cells. Nevertheless, these results could be important since
LLC-PK1 can physiologically handle oxalate ions [33] but
once exposed to calcium oxalate crystals, a rare situation,
shows a concentration-related increase in necrosis and
glycosaminoglycan synthesis. Also, MDCK cells are fre-
quently confronted to calcium oxalate crystals and could
control their endocytosis, but once injured by oxalate, in-
duce an up-regulation of glycosaminoglycans. These find-
ings suggest that in our conditions, tubular cells show
specificities to oxalate and calcium oxalate crystals treat-
ment and the surviving cells increase glycosaminoglycan
synthesis to protect against their deleterious effects.
Increase the cytosolic Ca2+ levels inhibit 35S-
glycosaminoglycan synthesis induced by calcium oxalate
crystals in proximal tubular cells. Campos and Schor [46]
showed that thapsigargin inhibit calcium oxalate crystals
endocytosis in MDCK. If it is also happening in our con-
ditions, it is possible that 35S-glycosaminoglycan synthesis
is inhibited because the endocytosis was prevented.
Another mechanism is related to K2-oxalate
effect since tapsigargin did not modify the 35S-
glycosaminoglycans synthesis induced by K2-oxalate in
MDCK. Iida et al [47] observed that oxalate exposure
increased intracellular calcium, as a sign of injury, and
it was prevented by heparan sulfate. It is possible that
oxalate induces up-regulation of glycosaminoglycan to
revert the damage.
CONCLUSION
High oxalate concentrations propitiate calcium ox-
alate crystallization and both calcium oxalate crystal and
oxalate ions induce tubular injury that could promote
crystals nucleation. Tubular cells may protect from the
toxic insult by inducing the synthesis of crystallization in-
hibitors, like glycosaminoglycans. Our work shows that
oxalate ions and calcium oxalate crystals increase gly-
cosaminoglycan synthesis in tubular epithelial cells and
could partially limit the stone formation and nephrolithi-
asis development.
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